Milestone #1: Launched Pink Ribbon Red Ribbon, a first of its kind partnership to combat cervical and breast cancer. In 2001, President Bush...
Milestone #1: Launched Pink Ribbon Red Ribbon, a first of its kind partnership to combat cervical and breast cancer. In 2001, President Bush announced the first commitment of his Administration to fight the spread of preventable disease in Africa, called the President’s Emergency Plan For AIDS Relief (PEPFAR). A decade later, 4.7 million people received anti-retrovirals through PEPFAR and The Global Fund, bringing the total to 6.6 million people in developing countries who received life saving AIDS medications thanks to the leadership of private organizations, national governments, and the international community. The next evolution of that groundbreaking initiative? Pink Ribbon Red Ribbon®, an innovative partnership between the Bush Institute, the U.S. Department of State President’s Emergency Plan for AIDS Relief (PEPFAR), Susan G. Komen for the Cure®, the Joint United Nations Programme on HIV/AIDS (UNAIDS), and other private partners. Pink Ribbon Red Ribbon leverages public and private investments and existing health infrastructures to combat two of the leading causes of cancer death among women in Sub-Saharan Africa and Latin America – cervical and breast cancer. 
In September, Secretary of State Hillary Rodham Clinton, Ambassador Nancy Brinker, Ambassador Eric Goosby and Mr. Michel Sidibé joined President and Mrs. Bush to announce Pink Ribbon Red Ribbon in Washington, D.C. 
In December, during President and Mrs. Bush’s trip to Africa, the partnership announced that Zambia will be the first Pink Ribbon Red Ribbon® partner country, expanding the availability of vital cervical cancer screening and treatment, and breast care education to those in need. 
Pink Ribbon Red Ribbon has commitments of $75 million over five years, and is expected to grow to include additional participants and services. The goals are to reduce deaths from cervical cancer by an estimated 25 percent among women screened and treated through the initiative, significantly increase access to breast and cervical cancer prevention, screening and treatment programs, and create innovative models that can be scaled up and used globally.
